老年人适当使用质子抑制剂:担忧和解决方案
Jennifer Bolt1,2,3, Wade Thompson4, Colleen Inglis5,6
1University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver, BC, Canada. Jennifer.bolt@ubc.ca.
Drugs & aging
|November 21, 2025
概括
许多老年人不必要使用质子抑制剂 (PPI),增加风险. 药物优化和降低处方策略对于在这个人群中安全有效地管理胃酸疾病至关重要.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 质子抑制剂 (PPI) 被广泛使用,许多老年人不必要服用这些药物.
- 人们担心PPI可能会产生长期的不良影响,尽管并没有确定其因果关系.
- 不必要的PPI使用导致老年人多药和药丸负担.
研究的目的:
- 为了突出在老年人中可能不必要的质子抑制剂处方的问题.
- 讨论与长期PPI使用相关的风险和药物优化需求.
- 探索减少不必要的PPI使用和支持减缓处方的策略.
主要方法:
- 对PPI处方模式和老年人的不良影响现有文献的审查.
- 分析与PPI脱相关的担忧和障碍.
- 讨论药物优化的多维方法.
主要成果:
- 观察数据表明,PPI使用与骨折,痴呆和感染之间存在关联,但对因果关系的高质量证据有限.
- 在老年人群中,不必要的PPI处方率仍然很高.
- 抑郁症的障碍包括对复发的恐惧,时间限制和缺乏教育.
结论:
- 质子抑制剂 (PPI) 是药物优化的目标在老年人由于高不必要的使用率.
- 需要一种多维的方法,包括基于证据的处方,重新评估,教育和解药支持.
- 成功地解除PPI的处方需要解决障碍,并利用像逐渐缩减和非药物替代品这样的策略.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
812
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
812
Drug Dosing: Geriatric Patients
199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
200
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
200
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
176
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
176
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
214
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
214
Pharmacodynamics in Geriatric Patients: Effects of Age
172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172
